Minot De Blois Advisors LLC Biogen Inc. Transaction History
Minot De Blois Advisors LLC
- $109 Billion
- Q4 2024
A detailed history of Minot De Blois Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Minot De Blois Advisors LLC holds 32 shares of BIIB stock, worth $4,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$4,370% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
994Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.29 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.19 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.99 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.01 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$673 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...